Search by Drug Name or NDC

    NDC 62011-0312-03 nasal decongestant 30 mg/1 Details

    nasal decongestant 30 mg/1

    nasal decongestant is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Strategic Sourcing Services, LLC (Health Mart). The primary component is PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 62011-0312
    Product ID 62011-0312_4117b86a-d368-4004-aa4c-7d43e125e08f
    Associated GPIs 42101020100305
    GCN Sequence Number 005089
    GCN Sequence Number Description pseudoephedrine HCl TABLET 30 MG ORAL
    HIC3 B6V
    HIC3 Description DECONGESTANTS, ORAL
    GCN 20481
    HICL Sequence Number 002091
    HICL Sequence Number Description PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name nasal decongestant
    Proprietary Name Suffix non-drowsy
    Non-Proprietary Name Pseudoephedrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Strategic Sourcing Services, LLC (Health Mart)
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through n/a

    Package

    NDC 62011-0312-03 (62011031203)

    NDC Package Code 62011-0312-3
    Billing NDC 62011031203
    Package 4 BLISTER PACK in 1 CARTON (62011-0312-3) / 24 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 1981-08-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.05727
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description HM NASAL DECONGEST 30 MG TAB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis